Joseph Ho-Lun Chau

Title: Joseph Ho-Lun Chau: Innovator in Pharmaceutical Formulations

Introduction

Joseph Ho-Lun Chau is a notable inventor based in Whistler, Canada. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of extended release tablets for SGLT2 inhibitors.

Latest Patents

Joseph holds a patent for a novel pharmaceutical formulation that enhances the pharmacokinetic profile of the SGLT2 inhibitor bexagliflozin. His innovation allows for the formulation of this medication as an extended release tablet. Compared to standard immediate-release dosage forms, these tablets can achieve a lower peak plasma concentration while maintaining therapeutic plasma levels for an extended duration. This advancement enables the administration of lower doses without compromising the pharmacological effect.

Career Highlights

Joseph is currently associated with Theracosbio, LLC, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in drug formulation has positioned him as a valuable asset in the development of effective therapeutic options.

Collaborations

Joseph collaborates with talented professionals in his field, including Feng Wang and Ankit Shrivastava. Their combined efforts contribute to the advancement of pharmaceutical technologies.

Conclusion

Joseph Ho-Lun Chau is a pioneering inventor whose work in pharmaceutical formulations is making a significant impact in the medical field. His innovative approach to drug delivery systems exemplifies the importance of research and development in improving patient care.